New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions
Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semagluti...
18 Kesä 22min
Why Exercise Still Matters in the GLP-1 Drug Era
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity...
18 Kesä 4min
The Search for a Fentanyl Vaccine
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: Inside the Push for a Fentanyl Vaccine
12 Kesä 5min
New Insights on HFpEF in Patients With Severe Obesity
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: HFpEF May Be a D...
5 Kesä 4min
Ebola Outbreak Update
JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "A Rare Ebola Virus Is Spreading in the DRC—Here's What to Know." Related Content: A Rare Ebola Virus...
29 Touko 6min
Is There a Doctor on the Ship?
Joining from quarantine, Stephen Kornfeld, MD, discusses his experience stepping in as the ship's physician when hantavirus transformed his vacation cruise into a global public health concern. Relate...
29 Touko 17min
Bangladesh's New Measles Crisis
JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "More Than 19 000 Measles Cases in a Month—What the Current Outbreak in Bangladesh Signals to the World." Related ...
22 Touko 4min
